Table 1.
Characteristic | Contraceptive Use, % (95% CI) | P Valuec | ||||||
---|---|---|---|---|---|---|---|---|
LARCb (n = 51) |
Depo-Provera, Patch, or Ring (n = 142) |
Oral Contraceptive (n = 426) |
Condom (n = 926) |
Withdrawal or Other Method (n = 240) |
None (n = 382) |
Not Sure (n = 40) |
||
Total | 1.8 (1.2-2.7) | 5.7 (4.5-7.0) | 22.4 (19.3-25.9) | 40.8 (37.5-44.1) | 11.8 (9.5-14.7) | 15.7 (13.5-18.2) | 1.9 (1.2-2.9) | |
Race/ethnicity | ||||||||
Non-Hispanic white | 2.0 (1.2-3.3) | 4.8 (3.7-6.2) | 30.7 (26.9-34.7) | 37.7 (32.9-42.7) | 11.3 (8.4-15.2) | 11.9 (9.7-14.4) | 1.6 (0.7-3.5) | <.001 |
Non-Hispanic black | 1.7 (0.7-4.1) | 10.1 (5.9-16.8) | 7.3 (4.6-11.5) | 46.5 (40.0-53.0) | 10.3 (7.0-14.9) | 21.2 (16.2-27.3) | 2.8 (1.4-5.8) | |
Hispanic | 1.4 (0.7-2.8) | 5.2 (2.9-9.4) | 7.3 (4.8-10.8) | 45.9 (40.6-51.3) | 13.9 (9.8-19.2) | 23.7 (20.0-27.9) | 2.6 (1.5-4.5) | |
Other | 1.4 (0.5-4.3) | 4.6 (2.2-9.2) | 28.3 (17.5-42.4) | 39.1 (29.5-49.7) | 13.5 (6.6-25.4) | 12.6 (8.2-19.0) | 0.5 (0.1-3.5) | |
Grade | ||||||||
9 | 1.0 (0.3-3.2) | 2.9 (1.4-6.1) | 14.7 (10.0-21.1) | 47.0 (37.9-56.3) | 13.1 (8.8-18.9) | 18.1 (13.0-24.7) | 3.2 (1.5-6.8) | <.001 |
10 | 1.3 (0.5-3.1) | 5.5 (3.5-8.6) | 19.2 (14.2-25.4) | 44.0 (38.3-49.8) | 11.7 (7.8-17.3) | 17.3 (13.7-21.6) | 1.0 (0.3-3.1) | |
11 | 1.7 (0.9-3.1) | 6.6 (4.3-10.0) | 23.2 (17.4-30.2) | 40.3 (34.0-46.9) | 12.4 (9.1-16.7) | 13.0 (9.9-16.8) | 2.9 (1.1-7.3) | |
12 | 2.5 (1.4-4.5) | 6.3 (4.4-9.1) | 27.6 (22.2-33.8) | 36.0 (32.2-40.0) | 11.1 (8.2-14.9) | 15.5 (11.6-20.5) | 0.9 (0.5-2.0) |
Abbreviation: LARC, long-acting reversible contraception.
Data on primary method of pregnancy prevention are missing for 81 sexually active female students. The sample sizes are unweighted numbers; the percentages are weighted percentages.
Indicates intrauterine device or implant use.
Overall χ2.